{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T10:47:24Z","timestamp":1746787644957},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,11]],"date-time":"2013-08-11T00:00:00Z","timestamp":1376179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s11845-013-1001-3","type":"journal-article","created":{"date-parts":[[2013,8,10]],"date-time":"2013-08-10T00:51:12Z","timestamp":1376095872000},"page":"259-264","source":"Crossref","is-referenced-by-count":6,"title":["Promoter hypermethylation-mediated down-regulation of RUNX3 gene in human brain tumors"],"prefix":"10.1007","volume":"183","author":[{"given":"C. B.","family":"Avci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Dodurga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Y.","family":"Susluer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. O. D.","family":"S\u0131gva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Yucebas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. O.","family":"Caglar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Akalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dalbasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Oktar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gunduz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,11]]},"reference":[{"issue":"5","key":"1001_CR1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ptj\/82.5.496","volume":"82","author":"CI Hill","year":"2002","unstructured":"Hill CI, Nixon CS, Ruehmeier JL, Wolf LM (2002) Brain tumors. Phys Ther 82(5):496\u2013502","journal-title":"Phys Ther"},{"key":"1001_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK et al (2007) The 2007 WHO classiffication of tumours of the central nervous system. Acta Neuropathol 114:97\u2013109. doi: 10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1001_CR3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/ijc.27964","volume":"132","author":"LS Chuang","year":"2013","unstructured":"Chuang LS, Ito K, Ito Y (2013) RUNX family: regulation and diversification of roles through interacting proteins. Int J Cancer 132(6):1260\u20131271. doi: 10.1002\/ijc.27964","journal-title":"Int J Cancer"},{"issue":"10","key":"1001_CR4","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1128\/JVI.64.10.4808-4819.1990","volume":"64","author":"Y Kamachi","year":"1990","unstructured":"Kamachi Y, Ogawa E, Asano M et al (1990) Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J Virol 64(10):4808\u20134819","journal-title":"J Virol"},{"issue":"2","key":"1001_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(00)80986-1","volume":"84","author":"T Okuda","year":"1996","unstructured":"Okuda T, van Deursen J, Hiebert SW et al (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84(2):321\u2013330. doi: 10.1016\/S0092-8674(00)80986-1","journal-title":"Cell"},{"issue":"8","key":"1001_CR6","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.93.8.3444","volume":"93","author":"Q Wang","year":"1996","unstructured":"Wang Q, Stacy T, Binder M et al (1996) Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 93(8):3444\u20133449","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1001_CR7","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1242\/dev.126.11.2563","volume":"126","author":"T North","year":"1999","unstructured":"North T, Gu TL, Stacy T et al (1999) Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development 126(11):2563\u20132575","journal-title":"Development"},{"issue":"5","key":"1001_CR8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","volume":"89","author":"P Ducy","year":"1997","unstructured":"Ducy P, Zhang R, Geoffroy V et al (1997) Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89(5):747\u2013754. doi: 10.1016\/S0092-8674(00)80257-3","journal-title":"Cell"},{"issue":"5","key":"1001_CR9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(00)80258-5","volume":"89","author":"T Komori","year":"1997","unstructured":"Komori T, Yagi H, Nomura S et al (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89(5):755\u2013764. doi: 10.1016\/S0092-8674(00)80258-5","journal-title":"Cell"},{"issue":"1","key":"1001_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(02)00690-6","volume":"109","author":"QL Li","year":"2002","unstructured":"Li QL, Ito K, Sakakura C et al (2002) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109(1):113\u2013124. doi: 10.1016\/S0092-8674(02)00690-6","journal-title":"Cell"},{"issue":"10","key":"1001_CR11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nn925","volume":"5","author":"K Inoue","year":"2002","unstructured":"Inoue K, Ozaki S, Shiga T et al (2002) Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci 5(10):946\u2013954. doi: 10.1038\/nn925","journal-title":"Nat Neurosci"},{"key":"1001_CR12","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.2741\/3977","volume":"17","author":"K Lam","year":"2012","unstructured":"Lam K, Zhang DE (2012) RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis. Front Biosci 17:1120\u20131139. doi: 3977","journal-title":"Front Biosci"},{"issue":"1\u20132","key":"1001_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1615\/CritRevOncog.v16.i1-2.80","volume":"16","author":"JK Mangan","year":"2011","unstructured":"Mangan JK, Speck NA (2011) RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40\u00a0years in the making. Crit Rev Oncog 16(1\u20132):77\u201391","journal-title":"Crit Rev Oncog"},{"issue":"17","key":"1001_CR14","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-11-3893","volume":"72","author":"AM Dulak","year":"2012","unstructured":"Dulak AM, Schumacher SE, van Lieshout J et al (2012) Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res 72(17):4383\u20134393. doi: 10.1158\/0008-5472.CAN-11-3893","journal-title":"Cancer Res"},{"issue":"11","key":"1001_CR15","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1002\/jnr.21686","volume":"86","author":"V Vladimirova","year":"2008","unstructured":"Vladimirova V, Waha A, L\u00fcckerath K et al (2008) Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. J Neurosci Res 86(11):2450\u20132461. doi: 10.1002\/jnr.21686","journal-title":"J Neurosci Res"},{"issue":"2","key":"1001_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2008.09.006","volume":"112","author":"NS Nevadunsky","year":"2009","unstructured":"Nevadunsky NS, Barbieri JS, Kwong J et al (2009) RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecol Oncol 112(2):325\u2013330. doi: 10.1016\/j.ygyno.2008.09.006","journal-title":"Gynecol Oncol"},{"issue":"18","key":"1001_CR17","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/onc.2010.88","volume":"29","author":"LS Chuang","year":"2010","unstructured":"Chuang LS, Ito Y (2010) RUNX3 is multifunctional in carcinogenesis of multiple solid tumors. Oncogene 29(18):2605\u20132615. doi: 10.1038\/onc.2010.88","journal-title":"Oncogene"},{"issue":"5B","key":"1001_CR18","first-page":"3633","volume":"26","author":"K Miyagawa","year":"2006","unstructured":"Miyagawa K, Sakakura C, Nakashima S et al (2006) Down-regulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis. Anticancer Res 26(5B):3633\u20133643","journal-title":"Anticancer Res"},{"issue":"2","key":"1001_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.20551","volume":"113","author":"C Sakakura","year":"2005","unstructured":"Sakakura C, Hagiwara A, Miyagawa K et al (2005) Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int J Cancer 113(2):221\u2013228. doi: 10.1002\/ijc.20551","journal-title":"Int J Cancer"},{"issue":"4","key":"1001_CR20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1440-1746.2009.06191.x","volume":"25","author":"W Chen","year":"2010","unstructured":"Chen W, Gao N, Shen Y et al (2010) Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. J Gastroenterol Hepatol 25(4):823\u2013831. doi: 10.1111\/j.1440-1746.2009.06191.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1001_CR21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbrc.2003.12.079","volume":"314","author":"QL Li","year":"2004","unstructured":"Li QL, Kim HR, Kim WJ et al (2004) Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 314(1):223\u2013228. doi: S0006291X03026706","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1001_CR22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.onc.1209805","volume":"26","author":"W Mueller","year":"2007","unstructured":"Mueller W, Nutt CL, Ehrich M et al (2007) Downregulation of RUNX3 and TES by hypermethylation in glioblastoma. Oncogene 26(4):583\u2013593. doi: 10.1038\/sj.onc.1209805","journal-title":"Oncogene"},{"issue":"4","key":"1001_CR23","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/FOC-07\/10\/E3","volume":"23","author":"DL Commins","year":"2007","unstructured":"Commins DL, Atkinson RD, Burnett ME (2007) Review of meningioma histopathology. Neurosurg Focus 23(4):E3. doi: 10.3171\/FOC-07\/10\/E3","journal-title":"Neurosurg Focus"},{"issue":"3","key":"1001_CR24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jcp.2003.013011","volume":"57","author":"J Li","year":"2004","unstructured":"Li J, Kleeff J, Guweidhi A et al (2004) RUNX3 expression in primary and metastatic pancreatic cancer. J Clin Pathol 57(3):294\u2013299. doi: 10.1136\/jcp.2003.013011","journal-title":"J Clin Pathol"},{"issue":"4","key":"1001_CR25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1349-7006.2003.tb01447.x","volume":"94","author":"T Waki","year":"2003","unstructured":"Waki T, Tamura G, Sato M et al (2003) Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 94(4):360\u2013364. doi: 10.1111\/j.1349-7006.2003.tb01447.x","journal-title":"Cancer Sci"},{"issue":"2","key":"1001_CR26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jcb.22969","volume":"112","author":"YM Lee","year":"2011","unstructured":"Lee YM (2011) Control of RUNX3 by histone methyltransferases. J Cell Biochem 112(2):394\u2013400. doi: 10.1002\/jcb.22969","journal-title":"J Cell Biochem"},{"issue":"2","key":"1001_CR27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/onc.2008.377","volume":"28","author":"SH Lee","year":"2009","unstructured":"Lee SH, Kim J, Kim WH et al (2009) Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 28(2):184\u2013194. doi: 10.1038\/onc.2008.377","journal-title":"Oncogene"},{"issue":"20","key":"1001_CR28","doi-asserted-by":"crossref","first-page":"9347","DOI":"10.1158\/0008-5472.CAN-05-1647","volume":"65","author":"WJ Kim","year":"2005","unstructured":"Kim WJ, Kim EJ, Jeong P et al (2005) RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 65(20):9347\u20139354. doi: 10.1158\/0008-5472.CAN-05-1647","journal-title":"Cancer Res"},{"issue":"13","key":"1001_CR29","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/0008-5472.CAN-06-0369","volume":"66","author":"QC Lau","year":"2006","unstructured":"Lau QC, Raja E, Salto-Tellez M et al (2006) RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 66(13):6512\u20136520. doi: 10.1158\/0008-5472.CAN-06-0369","journal-title":"Cancer Res"},{"issue":"6","key":"1001_CR30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/gcc.20870","volume":"50","author":"DJ Birnbaum","year":"2011","unstructured":"Birnbaum DJ, Ad\u00e9la\u00efde J, Mamessier E et al (2011) Genome profiling of pancreatic adenocarcinoma. Genes Chromosomes Cancer 50(6):456\u2013465. doi: 10.1002\/gcc.20870","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"1001_CR31","first-page":"770","volume":"52","author":"JF Moley","year":"1992","unstructured":"Moley JF, Brother MB, Fong CT et al (1992) Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res 52(4):770\u2013774","journal-title":"Cancer Res"},{"issue":"9","key":"1001_CR32","first-page":"1990","volume":"53","author":"I Bi\u00e8che","year":"1993","unstructured":"Bi\u00e8che I, Champ\u00e8me MH, Matifas F et al (1993) Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res 53(9):1990\u20131994","journal-title":"Cancer Res"},{"issue":"11 Pt 1","key":"1001_CR33","first-page":"4678","volume":"41","author":"GM Brodeur","year":"1981","unstructured":"Brodeur GM, Green AA, Hayes FA et al (1981) Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41(11 Pt 1):4678\u20134686","journal-title":"Cancer Res"},{"issue":"2","key":"1001_CR34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<360::AID-CNCR21>3.0.CO;2-Q","volume":"83","author":"S Ishino","year":"1998","unstructured":"Ishino S, Hashimoto N, Fushiki S et al (1998) Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization. Cancer 83(2):360\u2013366","journal-title":"Cancer"},{"issue":"2","key":"1001_CR35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0165-4608(95)00064-V","volume":"83","author":"MJ Bello","year":"1995","unstructured":"Bello MJ, Leone PE, Nebreda P et al (1995) Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet 83(2):160\u2013164. doi: 016546089500064V","journal-title":"Cancer Genet Cytogenet"},{"issue":"14","key":"1001_CR36","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/sj.onc.1210848","volume":"27","author":"K Ichimura","year":"2008","unstructured":"Ichimura K, Vogazianou AP, Liu L et al (2008) 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas. Oncogene 27(14):2097\u20132108. doi: 10.1038\/sj.onc.1210848","journal-title":"Oncogene"},{"issue":"3","key":"1001_CR37","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1158\/1078-0432.1119.11.3","volume":"11","author":"V Barbashina","year":"2005","unstructured":"Barbashina V, Salazar P, Holland EC et al (2005) Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 11(3):1119\u20131128. doi: 11\/3\/1119","journal-title":"Clin Cancer Res"}],"container-title":["Irish Journal of Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-013-1001-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-013-1001-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-013-1001-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T20:08:44Z","timestamp":1688414924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-013-1001-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,11]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1001"],"URL":"https:\/\/doi.org\/10.1007\/s11845-013-1001-3","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,11]]}}}